These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23253759)

  • 1. Next steps in designing for diffusion of pre-exposure prophylaxis: demonstration projects.
    Dearing JW; Norton WE; Larson RS
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S156-60. PubMed ID: 23253759
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-exposure prophylaxis for HIV: can it be implemented in the real world?
    Katz MH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S161-2. PubMed ID: 23253760
    [No Abstract]   [Full Text] [Related]  

  • 3. Providing HIV pre-exposure prophylaxis: lessons learned from the Ryan White HIV/AIDS Program.
    Trent-Adams S; Cheever LW
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S147-50. PubMed ID: 23253757
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings.
    Hosek SG
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S129-32. PubMed ID: 23253753
    [No Abstract]   [Full Text] [Related]  

  • 5. From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
    Warren MJ; Bass ES
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S167-70. PubMed ID: 23253762
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
    Curran JW; Crosby RA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S163-6. PubMed ID: 23253761
    [No Abstract]   [Full Text] [Related]  

  • 7. A proposed framework to monitor daily oral antiretroviral pre-exposure prophylaxis in the U.S.
    Smith DK; Beltrami J
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S141-6. PubMed ID: 23253756
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing for diffusion of a biomedical intervention.
    Dearing JW; Smith DK; Larson RS; Estabrooks CA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S70-6. PubMed ID: 23253765
    [No Abstract]   [Full Text] [Related]  

  • 9. Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S.
    Smith DK; Dearing JW; Sanchez T; Goldschmidt RH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S59-62. PubMed ID: 23253763
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying chronic illness care, implementation science, and self-management support to HIV.
    Elzarrad MK; Eckstein ET; Glasgow RE
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S99-107. PubMed ID: 23253770
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary care and public health partnerships for implementing pre-exposure prophylaxis.
    Norton WE; Larson RS; Dearing JW
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S77-9. PubMed ID: 23253766
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.
    Cohen SE; Liu AY; Bernstein KT; Philip S
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S80-5. PubMed ID: 23253767
    [No Abstract]   [Full Text] [Related]  

  • 13. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis.
    Philpott S
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S137-40. PubMed ID: 23253755
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.
    Edelman EJ; Fiellin DA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S86-90. PubMed ID: 23253768
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
    Horberg M; Raymond B
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752
    [No Abstract]   [Full Text] [Related]  

  • 16. Provider-initiated HIV-risk behavior counseling in the context of HIV pre-exposure prophylaxis.
    Thrun MW
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S108-11. PubMed ID: 23253749
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief risk-reduction counseling in clinical settings for HIV pre-exposure prophylaxis.
    Malotte CK
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S112-8. PubMed ID: 23253750
    [No Abstract]   [Full Text] [Related]  

  • 18. Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.
    Tilson HH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S151-5. PubMed ID: 23253758
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.
    Campbell JD; Herbst JH; Koppenhaver RT; Smith DK
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S63-9. PubMed ID: 23253764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urgent need for demonstration projects in Portugal to produce pre-exposure prophylaxis-related data.
    Rocha M; Deniel A; Mereiles P; Fuertes R; Barros H; Bernier A
    Int J STD AIDS; 2016 Sep; 27(10):920-1. PubMed ID: 27566798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.